Bronchogenic Carcinoma (DBCOND0028277)

Identifiers

Synonyms

Bronchogenic Cancer / Carcinoma, Bronchogenic / Bronchogenic carcinoma / Carcinoma bronchiogenic / Bronchial carcinoma / Squamous cell carcinoma of bronchus (disorder) / Cancer of bronchus / Malignant tumor of bronchus (disorder)

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Gallium chloride Ga-67	A radioactive isotope of gallium usually complexed with sodium citrate used to test for Hodgkin's disease, lymphoma, and bronchogenic carcinoma, and acute inflammatory lesions.	No drug targets
Gallium citrate Ga-67	A radiopharmaceutical agent used in the detection of the presence and extent of Hodgkin's disease, lymphoma, and bronchogenic carcinoma, as well as some acute inflammatory lesions.	Serotransferrincarrier Lactotransferrincarrier Ferritin light chaincarrier Ferritin heavy chaincarrier
Mechlorethamine	An antineoplastic agent used to treat Hodgkin's disease, lymphosarcoma, and chronic myelocytic or lymphocytic leukemia.	DNAtarget Cholinesteraseenzyme

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04710459	Endobronchial Cryotherapy in Management of MEBO in Patients With Inoperable NSCLC	No drug interventions	treatment	Not Available	completed
NCT03044769	Congenital Lung Anomalies (CLA) Swiss Database	No drug interventions	Not Available	Not Available	recruiting
NCT03331588	Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer	No drug interventions	treatment	3	completed
NCT01058785	Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer	No drug interventions	treatment	2	completed
NCT06177925	A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC	Adebrelimab Carboplatin Cisplatin Etoposide	treatment	2	recruiting
NCT03402048	The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial	Carboplatin Docetaxel Gemcitabine Pemetrexed Vinorelbine	treatment	3	unknown_status
NCT05241873	(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations	Carboplatin Pemetrexed	treatment	1 / 2	active_not_recruiting
NCT04862780	(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC	Osimertinib Tigozertinib	treatment	1 / 2	active_not_recruiting
NCT04222972	A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)	Carboplatin Cisplatin Gemcitabine Paclitaxel Pembrolizumab Pemetrexed Pralsetinib	treatment	3	active_not_recruiting
NCT02441972	Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics	No drug interventions	diagnostic	1	unknown_status
NCT03134872	A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC	Camrelizumab Carboplatin Pemetrexed	treatment	3	completed
NCT04697446	External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC	No drug interventions	Not Available	Not Available	unknown_status
NCT00102505	A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)	Motexafin gadolinium	treatment	1	completed
NCT03037385	Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors	Pralsetinib	treatment	1 / 2	completed
NCT04644315	A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors	Alectinib	treatment	2	terminated
NCT02804100	Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients	No drug interventions	Not Available	Not Available	unknown_status
NCT06494241	Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study	No drug interventions	Not Available	Not Available	not_yet_recruiting
NCT03085069	A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC	Camrelizumab	treatment	2	active_not_recruiting
NCT05153408	(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC	Carboplatin Osimertinib Pemetrexed	treatment	1	terminated
NCT06376084	Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC	No drug interventions	Not Available	Not Available	recruiting
NCT00652769	A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST)	No drug interventions	diagnostic	3	completed
NCT00001515	Diagnostic Effectiveness of Virtual Bronchoscopy	No drug interventions	treatment	1	completed
NCT00407264	Randomized Trial of Fluticasone in Bronchial Premalignancy	Fluticasone propionate	prevention	2	completed